Showing 1 - 10 of 7,929
crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in … the US pharmaceutical industry. We estimate the effect of patent length and scope on generic entry prior to the expiration … of new drug patents using two quasi-experimental approaches: one based on changes in patent laws and another on the …
Persistent link: https://www.econbiz.de/10012802183
Persistent link: https://www.econbiz.de/10011297589
Persistent link: https://www.econbiz.de/10012433661
Persistent link: https://www.econbiz.de/10001491302
Persistent link: https://www.econbiz.de/10012642904
Persistent link: https://www.econbiz.de/10012879754
A patent only protects an innovator from others producing the same product, but it does not protect him from others … within-patent competition, which results from production of the same product, and betweenpatent competition, which results … effects of intellectual property regulations on within -patent competition by showing how protecting innovative returns from …
Persistent link: https://www.econbiz.de/10012469403
of agreements by which brand-name drug companies pay generics to settle patent litigation and delay entering the market … of the patent" test applied by the dissent and several appellate courts — would have meant "game over" for challenges to …
Persistent link: https://www.econbiz.de/10014155650
. Illustrative is the barrier against access to essential medicines caused by pharmaceutical patent protection under the WTO regime …
Persistent link: https://www.econbiz.de/10013139675
crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in … the US pharmaceutical industry. We estimate the effect of patent length and scope on generic entry prior to the expiration … of new drug patents using two quasi-experimental approaches: one based on changes in patent laws and another on the …
Persistent link: https://www.econbiz.de/10013309494